Biotech

All Articles

Rivus' phase 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its fat-busting, muscle-sp...

Ovid halts preclinical job, IV system after soticlestat neglect

.Ovid Therapeutics already disclosed last month that it was actually trimming its own head count as ...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened up a $700 million R&ampD facility in the Boston Port, improving its o...

Boundless Biography helps make 'modest' unemployments five months after $100M IPO

.Merely five months after securing a $one hundred million IPO, Boundless Biography is actually curre...

Halda's $126M will definitely progress 'hold and also get rid of' cyst medications

.The initial phases of oncology R&ampD aren't short of interesting new techniques, and Halda Therapi...

Lykos 'remorses' not making known research infractions along with author

.Psychopharmacology has taken 3 articles about midstage medical trial data determining Lykos Rehabs'...

Analysts dig into Avidity's DMD gain, uncovering nuances in records

.Avidity Biosciences impressed investors along with phase 1/2 records in Duchenne muscle dystrophy (...

Actinogen's cortisol blocker neglects phase 2 clinical depression study

.Actinogen Medical's cortisol blocker has missed the primary endpoint of a period 2 research study i...

Bivictrix decides going private only method to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have gone to the center of lots of a billion-dollar biobuck licensi...

TPG leadings up funds to $580M for investments throughout life scientific researches

.Resource supervisor TPG, which has supported biotechs including Sionna Therapies as well as Santa A...